Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 44 45 46 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Genzyme–Univ Konstanz: diagnostics, <201011 collab diagnosis of seldom genetic metabolic diseases Prof Michael Przybylski 2010-11-30
NN–Tecan: lab automation equipment, 201011– supply OEM fully automated instrument + plastic consumable to global diagnostics company 2010-11-30
United Nations–Qiagen: ESE-Quant Tube Scanner, 201011– inital supply of up to 50 instruments via Joint FAO/IAEA Program to emerging countries 2010-11-29
Merck (DE)–Evotec: drug discovery services, 201011– collab developm pre-clinical candidates for neurological disease within Neu² Consortium 2010-11-23
Biotype Diagnostic–Oxford Gene Technology: microarray technology, 201011– license to OGT patents for detection of DNA sequence variations 2010-11-22
Merck (DE)–Agilent: electronic lab notebook, 201011– supply €na ww use of Agilent OpenLAB ELN by approx 600 Merck-Serono biology researchers 2010-11-22
Ono Pharmaceutical–Paion: remimazolam, 201011 collab existent partnering CNS 7056 for developm in Japan with Ono 2010-11-22
Covaris–Tecan: automated sample preparation, 201011– collab co-marketing Freedom EVO with integrated Adaptive Focused Acoustics 2010-11-18
Univ Konstanz–Bruker Corp: mass spectrometer, 201011 supply existent Esquire 3000+ ion trap ESI-MS from Bruker Daltonik 2010-11-18
Actelion–Amgen: investment, 201011– RUMOURS OF possible acquisition offer by Amgen NO OFFER MADE YET 2010-11-17
Leukocare–SEVERAL: investment, 201011 financing round €1.6m capital increase with existent shareholders 2010-11-17
LeukoDx–thinXXS: microfluidics technology, 201011– supply developm of microfluidics cartridge by thinXXS for POC micro-flow cytometry system 2010-11-17
Siemens–Wilex: investment, 201011 acquisition assets of Oncogene Science business entity of Siemens Healthcare Diagnostics for €500k in cash 2010-11-17
BioGenes–b3c communications: public relations, 201011 service existent PR distribution via b3c newswire 2010-11-16
Graffinity–Novalix: investment, 201011– acquisition €na of majority interest by Novalix SAS 2010-11-16
Predictive Biosciences–Epigenomics: mGSTP1 biomarker, 201011– license non-excl extension €na for developm + sale of prostate cancer test 2010-11-16
SAW Instruments–Univ Konstanz: sam5 SAW biosensor, 201011 collab developm of bioaffinity-MS tandem ESI solution incl sam5 biosensor Prof Przybylski 2010-11-15
Delenex–SEVERAL: investment, 201011 financing round series A CHF13.5m (€10m) led by SVLS + HBM Bio + BioMedInvest + VI Partners 2010-11-12
Bavaria (govt)–Biocom: online marketing, 201011 supply service production Bio-M.TV 2010-11-10
Bavaria (govt)–Biocom: online marketing, 201011– production of Bio-M.TV for BioM by Biocom AG 2010-11-10
Micromet–SEVERAL: investment, 201011 public offering $72.3m net $70.5m 9.9m shares common stock $7.3/share 2010-11-10
Bruker Corp–Univ Göttingen: mass spectrometry, 201011 collab developm identification multicellular fungi with MALDI Biotyper Inst Medical Microbiology 2010-11-09
Caprotec–LBBW: investment, 201011 financing round Series B €1m 2nd closing with sole investor LBBW Venture Capital GmbH 2010-11-09
Univ Göttingen–Bruker Corp: mass spectrometer, 201011 supply MALDI Biotyper installed at Institute for Medical Microbiology at UMG 2010-11-09
mtm Laboratories–SEVERAL: investment, 201011 financing round addit tranche Series C €7m lead investors HBM + Wellington Partners + Gilde Healthcare 2010-11-08
Focus Clinical Drug Development–Adcuram: investment, 201011 acquisition of Focus by Nuvisan Group 2010-11-05
Biocartis–Mérieux: investment, 201011– equity investment 9€m in connection w strategic collaboration bioMérieux 2010-11-04
Biocrea–Biotie: investment, 201011 acquisition of minority position + funding of up to €4.8m by Biotie in management spin-out Biocrea 2010-11-04
Mérieux–Biocartis: molecular diagnostics, 201011–201311 strategic collab ww co-developm + marketing microbiol assays bioMérieux TERMINATED 11/13 2010-11-04
Hopp Group–Wilex: investment, 201011–2011Q1 acquisition €19.2m 100% of Heidelberg Pharma AG in shares by Wilex AG 2010-11-03
M-Scan–SGS: investment, 201011 acquisition 2010-11-01
PANOPTES project–EU (govt): grant, 201011–201410 FP7 funding €3.9m out of total project cost of €5.45m 2010-11-01
Q-Bioanalytic–Germany (govt): grant, 201011–201310 BMBF grant €264k for Q-Bionalytic GmbH within VibrioNet project 2010-11-01
Roche–DNA Electronics: DNA sequencing, 201011–201304 collab €na excl partnership + non-excl IP license for sequencing system DISSOLVED by Roche 4/13 2010-11-01
Techpool Bio-Pharma–Nycomed: investment, 201011 acquisition €na 51.34% replacing Shanghai Pharmaceutical Group as largest shareholder 2010-11-01
MeVis–Allianz: investment, 201010 existent Allianz Global Investors owns 3.3% of MeVis Medical Solutions AG 2010-10-31
MeVis–Fortelus: investment, 201010 existent Fortelus Special Situations Master Fund Ltd owns 10.8% of MeVis Medical Solutions AG 2010-10-31
MeVis–M.M. Warburg: investment, 201010 existent 10/10 MM Warburg & Co KG owns 6.4% of MeVis Medical Solutions AG 2010-10-31
MeVis–PERSON: investment, 201010 existent 10/10 Carl JG Evertz owns 19.5% of MeVis Medical Solutions AG 2010-10-31
MeVis–PERSON: investment, 201010 existent 10/10 Hartmut Jürgens owns 16.5% of MeVis Medical Solutions AG 2010-10-31
MeVis–PERSON: investment, 201010 existent 10/10 Heinz-Otto Peitgen owns 19.5% of MeVis Medical Solutions AG 2010-10-31
MeVis–PERSON: investment, 201010 existent 10/10 Peter Kuhlmann-Lehmkuhle owns 3% of MeVis Medical Solutions AG 2010-10-31
Evolva–COFRA: investment, 201010 existent Evolva listed as portfolio company of Entrepreneurs Fund 2010-10-28
Jingxin Pharmaceuticals–Evotec: EVT 201, 201010– collab + license excl for developm + marketing in China 2010-10-28
Protaffin–COFRA: investment, 201010 existent Protaffin listed as portfolio company of Entrepreneurs Fund 2010-10-28
Stellacure–COFRA: investment, 201010 existent Stellacure listed as portfolio company of Entrepreneurs Fund 2010-10-28
Apeiron–Evotec: drug discovery services, 201010– collab €na identification DREAM modulators for pain treatment 2010-10-27
Merck (DE)–Evotec: drug discovery services, 201010– collab developm HT screening assay for a MS target by European ScreeningPort within Neu² project 2010-10-27
biosyn–Panatecs: mass spectrometry services, 201010 collab developm protein quantification MS method for mistletoe lectin 2010-10-26
Boehringer–MacroGenics: antibody technology, 201010– collab global alliance to discovery + develop + commericalise DART antibody-based therapeutics 2010-10-26
Abunda Nutrition–Evolva: food ingredients, 201010– collab expansion + extension €na 2y research production methods for high-value food ingredients 2010-10-25
Lonza–Becton Dickinson: molecular diagnostics, 201010– collab excl license + ww co-marketing BD MAX System with microCompass for quality control 2010-10-25
Curefab–High-Tech Gründerfonds: investment, 201010 financing round led by HTGF + Bayern Kapital 2010-10-20
Curefab–SEVERAL: investment, 201010 financing round led by HTGF + Bayern Kapital 2010-10-20
Evotec–Hypha Discovery: MycoDiverse natural compound library, 201010– supply extension to collab to evaluate MycoDiverse against ESP assay panel 2010-10-19
Lundbeck–Paion: desmoteplase, 201010– collab expansion to incl ww excl rights for follow-on compounds incl €1.5m upfront payment 2010-10-15
Pronto Diagnostics–Epigenomics: molecular diagnostics, 201010– distribution excl Epi proColon test in Israel by Pronto Diagnostics 2010-10-14
United Kingdom (govt)–MorphoSys: research antibodies, 201010– supply AbD Serotec 2 year contract as preferred supplier for RCUK SSC Ltd 2010-10-14
Protagen–MicroDiscovery: biomarker discovery, 201010– collab combining MicroDiscovery software with Protagen UNIarray technology 2010-10-13
MorphoSys–Germany (govt): grant, 201010– BMBF grant totalling €850k tog for MorphoSys + Proteros for collaborative project within m4 Initiative 2010-10-12
MorphoSys–Proteros: structure-based drug design, 201010– collab developm platform for antibody-antigen-complex characterisation 2010-10-12
Noxxon–SEVERAL: investment, 201009 financing round Series D 2nd closing additional €2m from CD Ventures + private investors 2010-10-12
Proteros–Germany (govt): grant, 201010– BMBF grant totalling €850k tog for MorphoSys + Proteros for collab project within m4 Initiative 2010-10-12
Qiagen–Abbott: molecular diagnostics, 201010– collab €na mutual access to PCR-based tests to broaden North American test portfolio for both 2010-10-12
BMS–Kinaxo: drug discovery services, 201010– collab Kinaxo to apply chemical proteomics technologies to deconvolute molecular targets of BMS compounds 2010-10-11
Caprotec–BioNTech: CCMS technology, <201010 collab development capture compounds for peptides JPT Peptide Technologies GmbH 2010-10-07
Novartis–Cepheid: pharmacogenetic test, 201010– collab ww excl Xpert BCR-ABL test for treatment monitoring w tyrosine kinase inhibitors 2010-10-07
Sloning–MorphoSys: investment, 201010 acquisition €19m in cash 2010-10-07
Symetis–SEVERAL: investment, 201010 financing round CHF25m co-led by Endeavour Vision + NBGI Ventures 2010-10-07
Epigenomics–NextPharma: contract manufacturing, 201010– service global manufacturing Epi proColon in San Diego for Epigenomics 2010-10-06
Affimed–MC Services: public relations, 201010 service existent for AbCheck sro 2010-10-05
Eucodis Bioscience–Evocatal: industrial enzymes, 201010– collab €na co-marketing of each other’s products 2010-10-05
Evotec–Promega: research assays, 201010– collab developm assays for HTS with compound libraries European ScreeningPort 2010-10-05
Lilly–Affimed: drug discovery services, 201010– service €na use AbCheck discovery libraries to deliver fully human ABs against Lilly targets 2010-10-05
Promega–Vocato public relations: public relations, 201010 service existent for Promega GmbH 2010-10-05
SAW Instruments–Alto Marketing: public relations, 201105 service existent 2010-10-05
Shionogi–Evotec: drug discovery services, 201010– service €na fragment-based identification of small molecule modulators using EVOlution 2010-10-05
Enzymicals–Evonik: enzymes, 201010– acquisition of IP for range of PLE isoenzymes 2010-10-04
Beijing ExtraTech–Hyden Analytical: mass spectrometer, 201010 distribution existent in China by Beijing ExtraTech Analytical Ltd 2010-10-03
Canada Analytical & Process Technologies–European Spectrometry Systems: mass spectrometer, 201010 distribution existent in Canada 2010-10-03
Massanalys–InProcess Instruments: mass spectrometer, 201010 distribution existent in Nordic Countries by Massanalys Spectrometry Nordic AB 2010-10-03
Corimmun–SEVERAL: investment, 201010 financing round Series B €7.5m led by MIG AG incl Bayern Kapital + Bio-M + HTGF + KfW 2010-10-01
Merck (DE)–Ablynx: Nanobodies, 201010– collab co-discovery + co-developm Nanobodies against one target in inflammation Merck Serono 2010-10-01
SUBMARINER project–EU (govt): grant, 201010–201312 ERDF funding €2.8m out of total budget of €3.6m 2010-10-01
Atlas Biolabs–Cartagenia: BENCH software, 201009– license to Cartagenia BENCH software for analysis of genetic DNA chip data 2010-09-30
Biametrics–High-Tech Gründerfonds: investment, 201009 financing round totalling €600k from HTGF + Seedfonds Baden-Württemberg 2010-09-30
Biametrics–SEVERAL: investment, 201009 financing round €600k from HTGF + Seedfonds Baden-Württemberg 2010-09-30
Becton Dickinson–Bruker Corp: mass spectrometer, 201009– collab co-developm + -marketing of integrated Biotyper + BD Phoenix + BD EpiCenter solution 2010-09-29
Berlin (govt)–Danaher: mass spectrometer, 201009 supply existent AB Sciex QSTAR XLC-QqTOF system at BBGes Clinical Toxicology 2010-09-29
Berlin (govt)–GeneBio: SmileMS software, 201009– supply use for creation of MSMS spectra library of drugs using AB Sciex QSTAR by BBGes 2010-09-29
Daiichi Sankyo–Kinaxo: drug discovery services, 201009– collab long-term €na use of Kinaxo technologies for cancer drug development 2010-09-29
Kinaxo–b3c communications: public relations, 201009 service existent PR distribution via b3c newswire 2010-09-29
Cevec–b3c communications: public relations, 201009 service existent PR distribution via b3c newswire 2010-09-28
Mucosis–b3c communications: public relations, 201009 service existent PR distribution via b3c newswire 2010-09-28
Sanofi-Aventis–Pieris: Anticalin technology, 201010– collab discovery + license ww Anticalins for Sanofi targets €3.5m upfront + milestones+royalties 2010-09-28
APM Engineering–Ionicon: PTR mass spectrometer, 201009 distribution existent in Japan by APM Engineering Co Ltd 2010-09-27
Artes Biotechnology–b3c communications: public relations, 201009 service existent PR distribution via b3c newswire 2010-09-27
Artes Biotechnology–Select Vaccines: Anavax VLP technology, 201009 acquisition of Anavax technology by Artes 2010-09-27
Beijing ExtraTech–Ionicon: PTR mass spectrometer, 201009 distribution existent in China by Beijing ExtraTech Analytical Ltd 2010-09-27
Biotage–b3c communications: public relations, 201009 service existent PR distribution via b3c newswire 2010-09-27
next pagenext page 1 2 3 ... 44 45 46 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top